Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment).


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 30 10 2018
accepted: 05 12 2018
pubmed: 2 2 2019
medline: 13 9 2019
entrez: 2 2 2019
Statut: ppublish

Résumé

Respiratory tract infections (RTI) are more commonly caused by viral pathogens in children than in adults. Surprisingly, little is known about antibiotic use in children as compared to adults with RTI. This prospective study aimed to determine antibiotic misuse in children and adults with RTI, using an expert panel reference standard, in order to prioritise the target age population for antibiotic stewardship interventions. We recruited children and adults who presented at the emergency department or were hospitalised with clinical presentation of RTI in The Netherlands and Israel. A panel of three experienced physicians adjudicated a reference standard diagnosis (i.e. bacterial or viral infection) for all the patients using all available clinical and laboratory information, including a 28-day follow-up assessment. The cohort included 284 children and 232 adults with RTI (median age, 1.3 years and 64.5 years, respectively). The proportion of viral infections was larger in children than in adults (209(74%) versus 89(38%), p < 0.001). In case of viral RTI, antibiotics were prescribed (i.e. overuse) less frequently in children than in adults (77/209 (37%) versus 74/89 (83%), p < 0.001). One (1%) child and three (2%) adults with bacterial infection were not treated with antibiotics (i.e. underuse); all were mild cases. This international, prospective study confirms major antibiotic overuse in patients with RTI. Viral infection is more common in children, but antibiotic overuse is more frequent in adults with viral RTI. Together, these findings support the need for effective interventions to decrease antibiotic overuse in RTI patients of all ages.

Identifiants

pubmed: 30707378
doi: 10.1007/s10096-018-03454-2
pii: 10.1007/s10096-018-03454-2
pmc: PMC6394715
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-514

Subventions

Organisme : FP7 Ideas: European Research Council
ID : 602860

Références

Clin Infect Dis. 2005 Nov 15;41(10):1438-44
pubmed: 16231254
Acta Clin Belg. 2006 Jul-Aug;61(4):161-5
pubmed: 17091911
Health Technol Assess. 2007 Dec;11(50):iii, ix-51
pubmed: 18021577
Emerg Infect Dis. 2008 Nov;14(11):1722-30
pubmed: 18976555
J Clin Epidemiol. 2009 Aug;62(8):797-806
pubmed: 19447581
Minerva Pediatr. 2009 Oct;61(5):489-501
pubmed: 19794375
Lancet. 2010 Mar 6;375(9717):834-45
pubmed: 20132979
BMJ. 2010 Apr 20;340:c1594
pubmed: 20406860
J Med Virol. 2012 Jun;84(6):906-11
pubmed: 22499014
PLoS Med. 2013 Oct;10(10):e1001531
pubmed: 24143138
Lancet Infect Dis. 2013 Dec;13(12):1057-98
pubmed: 24252483
Antimicrob Agents Chemother. 2014;58(3):1451-7
pubmed: 24342652
Pediatrics. 2014 Oct;134(4):e956-65
pubmed: 25225144
PLoS One. 2014 Dec 11;9(12):e115061
pubmed: 25503770
PLoS One. 2015 Mar 18;10(3):e0120012
pubmed: 25785720
Lancet. 2016 Apr 23;387(10029):1743-52
pubmed: 26898856
Open Forum Infect Dis. 2016 Feb 23;3(1):ofw045
pubmed: 27006968
JAMA. 2016 May 3;315(17):1864-73
pubmed: 27139059
PLoS One. 2016 Aug 03;11(8):e0160278
pubmed: 27486746
Lancet Infect Dis. 2017 Apr;17(4):431-440
pubmed: 28012942
Am J Emerg Med. 2018 Feb;36(2):218-225
pubmed: 28774769
J Antimicrob Chemother. 2018 May 1;73(5):1416-1422
pubmed: 29438547
BMC Infect Dis. 2018 Aug 7;18(1):377
pubmed: 30086729

Auteurs

Chantal B van Houten (CB)

Division of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht University, P.O. Box 85090, Office KC.03.063.0, 3508 AB, Utrecht, The Netherlands.

Asi Cohen (A)

MeMed, Tirat Carmel, Israel.

Dan Engelhard (D)

Division of Paediatric Infectious Disease Unit, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.

John P Hays (JP)

Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Roger Karlsson (R)

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Edward Moore (E)

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

David Fernández (D)

Noray Bioinformatics, Derio, Spain.

Racheli Kreisberg (R)

IBEXperts Ltd, Ra'anana, Israel.

Laurence V Collins (LV)

IBEXperts Ltd, Ra'anana, Israel.

Wouter de Waal (W)

Department of Paediatrics, Diakonessenhuis, Utrecht, The Netherlands.

Karin M de Winter-de Groot (KM)

Department of Paediatric Respiratory Medicine, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

Tom F W Wolfs (TFW)

Division of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht University, P.O. Box 85090, Office KC.03.063.0, 3508 AB, Utrecht, The Netherlands.

Pieter Meijers (P)

Department of Paediatrics, Gelderse Vallei Hospital, Ede, The Netherlands.

Bart Luijk (B)

Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

Jan Jelrik Oosterheert (JJ)

Department of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht, Utrecht University, Utrecht, The Netherlands.

Rik Heijligenberg (R)

Department of Internal Medicine, Gelderse Vallei Hospital, Ede, The Netherlands.

Sanjay U C Sankatsing (SUC)

Department of Internal Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands.

Aik W J Bossink (AWJ)

Department of Respiratory Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands.

Andrew Stubbs (A)

Department of Bioinformatics, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Michal Stein (M)

Department of Paediatrics, Hillel Yaffe Medical Centre, Hadera, Israel.

Sharon Reisfeld (S)

Department of Paediatrics, Hillel Yaffe Medical Centre, Hadera, Israel.

Adi Klein (A)

Department of Paediatrics, Hillel Yaffe Medical Centre, Hadera, Israel.

Ronit Rachmilevitch (R)

Department of Paediatrics, Hillel Yaffe Medical Centre, Hadera, Israel.

Jalal Ashkar (J)

Department of Paediatrics, Hillel Yaffe Medical Centre, Hadera, Israel.

Itzhak Braverman (I)

Department of Paediatrics, Hillel Yaffe Medical Centre, Hadera, Israel.

Valery Kartun (V)

Department of Paediatrics, Hillel Yaffe Medical Centre, Hadera, Israel.

Irena Chistyakov (I)

Department of Paediatrics, Bnai Zion Medical Centre, Haifa, Israel.

Ellen Bamberger (E)

Department of Paediatrics, Bnai Zion Medical Centre, Haifa, Israel.

Isaac Srugo (I)

Department of Paediatrics, Bnai Zion Medical Centre, Haifa, Israel.

Majed Odeh (M)

Department of Paediatrics, Bnai Zion Medical Centre, Haifa, Israel.

Elad Schiff (E)

Department of Paediatrics, Bnai Zion Medical Centre, Haifa, Israel.

Yaniv Dotan (Y)

Department of Internal Medicine, Bnai Zion Medical Centre, Haifa, Israel.

Olga Boico (O)

MeMed, Tirat Carmel, Israel.

Roy Navon (R)

MeMed, Tirat Carmel, Israel.

Tom Friedman (T)

MeMed, Tirat Carmel, Israel.

Liat Etshtein (L)

MeMed, Tirat Carmel, Israel.

Meital Paz (M)

MeMed, Tirat Carmel, Israel.

Tanya M Gottlieb (TM)

MeMed, Tirat Carmel, Israel.

Ester Pri-Or (E)

MeMed, Tirat Carmel, Israel.

Gali Kronenfeld (G)

MeMed, Tirat Carmel, Israel.

Einav Simon (E)

MeMed, Tirat Carmel, Israel.

Kfir Oved (K)

MeMed, Tirat Carmel, Israel.

Eran Eden (E)

MeMed, Tirat Carmel, Israel.

Louis J Bont (LJ)

Division of Paediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht University, P.O. Box 85090, Office KC.03.063.0, 3508 AB, Utrecht, The Netherlands. l.bont@umcutrecht.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH